Immunohistochemical detection of nuclear survivin in NSCLC: a comparison of commercial antibodies.
Vischioni
B
B
Oudejans
J J
JJ
Kruyt
F A E
FA
Giaccone
G
G
Rodriguez
J A
JA
D000911:Antibodies, Monoclonal; D014408:Biomarkers, Tumor / Q000378:metabolism; D002289:Carcinoma, Non-Small-Cell Lung / Q000378:metabolism* / Q000473:pathology; D002452:Cell Count; D002467:Cell Nucleus / Q000378:metabolism*; D003593:Cytoplasm / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D051034:Inhibitor of Apoptosis Proteins; D008175:Lung Neoplasms / Q000378:metabolism* / Q000473:pathology; D008869:Microtubule-Associated Proteins / Q000378:metabolism*; D009363:Neoplasm Proteins / Q000378:metabolism*; D015203:Reproducibility of Results; D000077022:Survivin
D000911:Antibodies, Monoclonal; C107489:BIRC5 protein, human; D014408:Biomarkers, Tumor; D051034:Inhibitor of Apoptosis Proteins; D008869:Microtubule-Associated Proteins; D009363:Neoplasm Proteins; D000077022:Survivin